Clinical Research Coach – Détails, épisodes et analyse

In this episode, I sat down with Paresh Shah, the Founder and CEO of CliniLink.

Paresh shared views on the importance of DE&I and accessibility in clinical trials, as well as social determinants of health and impact in clinical trial recruitment.

CliniLink Health stands out in revolutionizing patient engagement in clinical trials, through their AI enabled data platform.

To connect with Paresh, and find out more:

https://www.linkedin.com/in/pareshkshah/

In this episode, Joe Dustin, a long time industry leader, shares stories and wisdom gleaned from decades of experience. Joes's passion for the industry and the patients he serves is palpable. From his driving curiosity to excitement about the latest tech advancement, Joe's desire to connect and impact others is clearly a superpower. His advice to remember the people that matter in one's personal life serves as a poignant reminder to find balance.

Enjoy this episode!

To learn more about Joe, and connect with him on LinkedIn: https://www.linkedin.com/in/eclinical/

In this mini episode, with Kelsey Brown, Director of Medical Writing at TransPerfect, she shares the importance of health literacy to build relationships, trust and understanding with patients. You'll come away from this episode with practical tips to ensure you can connect with your intended audience in meaningful ways. Enjoy!

Heather Leverington Dotterer is an organ donor advocate, mom and former co-head coach for indoor and outdoor track and field at Lockhaven Univeristy. Heather is an elite athlete, 5 time national champion in shotput, and previous olympic hopeful. In this episode, Heather shares her story of going from athlete, to being in a wheelchair on oxygen as she waited for a lung transplant. Heather recounts her story with vulnerability and honesty as she shares about the waiting for donor lungs and the decision to enter a clinical trial with lungs that underwent an ex viva lung profusion. Heather reminds us of the power of relationships, and the gift of second chances. Her story is one of resiliency, mental toughness and a willingness to find solutions to break through and persevere.  

In this episode, Craig Serra, shares how he found his path in clinical research by cultivating a healthy sense of curiosity. He explains the importance of tenacity and follow through to bring solutions forward and the necessity of cultivating a thick skin. Craig offers sage advice for those wanting to get into the industry and how rejection can build character. We talk about lessons learned during covid and how to carry those forward to advance the industry. We address the issues of workload at clinical research sites and discuss how to alleviate some of the challenges of the most over burdened people in the industry. Craig's message of empathy and understanding will inspire and encourage you to look at things through a different lens. Enjoy!

Dr Daniel Fox is an advocate for clinical research sites. Living out his purpose driven mission of restoring basic business rights for sites. Dr Fox and I discuss the challenges of underfunded studies, why 70% of physicians who try clinical research never take on another study and the importance of efficiencies and trust in order to elevate the playing field and optimize clinical research. Dr Fox speaks of a collaborative network with unity in the industry and open communication. Truly a visionary, Dr Fox shares about his Good Clinical Business Practices (GCBP) training program and increasing access to clinical research through healthcare integration. 

Dr Daniel Fox is a translational researcher with almost 2 decades of experience in science, quality, and research. He has worked at small biotechs, global pharma, academic institutions, military bases, and clinical research sites.

Dr. Fox dedicates his life to ensuring patients receive new and innovative therapies as quickly, efficiently, and safely as possible. Currently, he focuses on site rights and advocacy to help patients, physicians, and sites access research opportunities as an integrated healthcare solution.

To find out more about Dr Fox:

Check out: https://www.crpaynet.com/

LinkedIn: https://www.linkedin.com/in/daniel-fox-mph-phd-3955b222/

In this episode, Kelsey Brown, Director of Medical Writing at TransPerfect, shares about the importance of plain language and health literacy. Health literacy is the degree in which someone understands text and can take action. Data suggests the lower one's health literacy, the poorer their health outcomes. It's critical that information be provided in a way in which patients can understand and take action. Kelsey shares tips for drafting plain language documents and tools to measure readability. 

We also discuss EU/CTR, the new regulations going into effect in January 2023, and what sponsor companies must do to be compliant.

For further questions and information, you can reach Kelsey at: medicalwriting@transperfect.com

To find out more about TransPerfect's Medical Writing: https://lifesciences.transperfect.com/medical-writing

To read Kelsey's recent white paper: CLINICAL DATA TRANSPARENCY & PUBLIC DISCLOSURES: OVERCOMING CHALLENGES WITH PROSPECTIVE WRITING https://marketing.transperfect.com/acton/fs/blocks/showLandingPage/a/687/p/p-00d0/t/page/fm/0

Danieska Sandino's experience from CRC to Director of Clinical Operations at a sponsor, gives her the ability to appreciate industry challenges from a broad perspective. In this far reaching episode we discuss how to handle turnover, managing expectations and the need for transparency and collaboration in the industry. Danieska shares practical tips and systems for onboarding staff, negotiating budgets and patient recruitment. We talk about bringing a protocol to life and how to support your team with mission driven goals. 

In this episode, we chat with, Lucy Coassin, Current Health's Senior Director of Pharma Partnerships. Lucy explains how Best Buy's entry into the healthcare sector with Current Health empowers patients and provides greater flexibility utilizing remote patient monitoring technology. We discuss the changing landscape of clinical trials and the need for greater collaboration, commitment and interoperability as we usher in this new age of healthcare. Lucy shares advice for those who wanting to get into the industry, as well as suggestions for getting industry to accept and adopt innovative technology.  

Lucy Coassin is the Senior Director of Pharma Partnerships at Current Health. Previously at Science 37, she is well versed in bringing revolutionary technology to the market. Lucy is a trailblazer, boldly brining transformational technology to the pharma industry. Lucy has an MBA from Stanford and a BS in Chemistry from Duke.   

Daniel A. Perez is a rebel in clinical research and passionate advocate for diversity and equity in healthcare. With a servant's heart and desire to lead, he elevates those around him while challenging the industry status quo. In this episode we chat about the state of the industry and what may transform the relationships with investigators and what is necessary to create a successful ecosystem at the site level. We talk about the importance of resources, education and financial compensation, layered in with empathy.  

A Los Angeles native, Daniel’s passion for clinical research materialized over a decade ago, when a new diagnosis forced him to face critical treatment options evolving only as fast as clinical trials allowed. It was during this experience when he recognized his fortune in benefitting from clinical research-fueled medical breakthroughs, as well as the unnecessary dysfunction and inefficiency that existed within this same space. With a newfound desire to make an impact on the traditional clinical trial paradigm, Daniel entered the neurosciences department at Cedars-Sinai Medical Center, where his talent and motivation led to several quick promotions within academia. It was in his expansive role as Clinical Research Manager at Children’s Hospital Los Angeles (CHLA) where Daniel fine-tuned his talents across all regulatory, managerial and operational aspects of clinical research. After recognizing the amplified impact possible outside of traditional medical institutions, and experiencing MACRO as a clinical operations consultant, he made the leap and joined MACRO full time. At MACRO, Daniel combined his meticulous operational acumen with his comprehensive research and regulatory expertise to help bring their vision into a tangible reality.

Daniel leads by constantly questioning how things have always been done, and continuously evaluating the clinical research process through the lens of the human subjects on which they are based. Daniel cofounded the Coalition for Advancing Research Equity (CARE) and also serves as a founding board member for Clinical Trials in Color, a 501(c)(3) non-profit foundation with a mission to improve health outcomes in communities of color by increasing diversity and access to clinical trials. Daniel is currently the Global Head, Patient Experience, Diversity & Inclusion at Worldwide Clinical Trials.